Dolby Laboratories Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Dolby Laboratories wird ein Gewinn- und Umsatzwachstum von 17.6% bzw. 5.6% pro Jahr prognostiziert, während der Gewinn pro Aktie um 22% pro Jahr wachsen soll.

Wichtige Informationen

17.6%

Wachstumsrate der Gewinne

22.0%

EPS-Wachstumsrate

Software Gewinnwachstum	33.2%
Wachstumsrate der Einnahmen	5.6%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	03 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

DB:FUO - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
9/30/2026	1,475	307	N/A	N/A	1
9/30/2025	1,363	270	N/A	N/A	3
9/30/2024	1,293	235	N/A	N/A	3
3/29/2024	1,269	190	365	396	N/A
12/29/2023	1,280	188	290	319	N/A
9/29/2023	1,300	201	337	367	N/A
6/30/2023	1,287	219	301	333	N/A
3/31/2023	1,279	242	348	385	N/A
12/30/2022	1,237	183	303	343	N/A
9/30/2022	1,254	184	259	319	N/A
7/1/2022	1,261	201	316	377	N/A
4/1/2022	1,258	216	314	377	N/A
12/31/2021	1,243	255	332	397	N/A
9/24/2021	1,281	310	393	448	N/A
6/25/2021	1,267	293	398	451	N/A
3/26/2021	1,228	306	359	413	N/A
12/25/2020	1,260	318	334	395	N/A
9/25/2020	1,162	231	275	344	N/A
6/26/2020	1,189	248	287	362	N/A
3/27/2020	1,245	221	234	319	N/A
12/27/2019	1,231	206	195	302	N/A
9/27/2019	1,242	255	214	328	N/A
6/28/2019	1,183	238	194	309	N/A
3/29/2019	1,096	201	253	360	N/A
12/28/2018	1,057	193	307	392	N/A
9/28/2018	1,055	42	267	352	N/A
6/29/2018	1,056	37	236	321	N/A
3/30/2018	1,147	110	216	317	N/A
12/29/2017	1,115	95	N/A	324	N/A
9/29/2017	1,080	206	N/A	378	N/A
6/30/2017	1,072	204	N/A	370	N/A
3/31/2017	1,044	192	N/A	359	N/A
12/30/2016	1,051	208	N/A	360	N/A
9/30/2016	1,026	186	N/A	360	N/A
7/1/2016	1,025	208	N/A	367	N/A
4/1/2016	980	180	N/A	288	N/A
1/1/2016	977	171	N/A	373	N/A
9/25/2015	971	181	N/A	309	N/A
6/26/2015	965	181	N/A	316	N/A
3/27/2015	956	185	N/A	360	N/A
12/26/2014	963	203	N/A	288	N/A
9/26/2014	960	206	N/A	362	N/A
6/27/2014	950	206	N/A	339	N/A
3/28/2014	934	196	N/A	332	N/A
12/27/2013	904	182	N/A	286	N/A
9/27/2013	910	189	N/A	277	N/A
6/28/2013	919	195	N/A	286	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: FUODas prognostizierte Gewinnwachstum (17.6% pro Jahr) liegt über der Sparquote (0.7%).

Ertrag vs. Markt: FUODie Erträge des Unternehmens (17.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt German (18.5% pro Jahr).

Hohe Wachstumserträge: FUODie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: FUODie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt German (5.1% pro Jahr).

Hohe Wachstumseinnahmen: FUODie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von FUO in 3 Jahren voraussichtlich hoch sein wird

Dolby Laboratories Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Dolby Laboratories, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Dolby Laboratories, Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2024

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2023

Dolby Laboratories, Inc. Provides Revenue Guidance for the Fiscal 2023

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2022

Dolby Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2022 and Full Year Fiscal 2022

Recent updates

Dolby Laboratories, Inc. (NYSE:DLB) entered into a definitive agreement to acquire Ge Trademark Licensing, Inc. from General Electric Company (NYSE:GE) for approximately $430 million.

Second quarter dividend of US$0.30 announced

Second quarter 2024 earnings released: EPS: US$1.02 (vs US$1.00 in 2Q 2023)

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on May 22, 2024

Dolby Laboratories, Inc. to Report Q2, 2024 Results on May 02, 2024

Senior VP & Chief Marketing Officer recently sold €933k worth of stock

Insufficient new directors

Dolby Laboratories, Inc. Announces Committee Changes

First quarter dividend of US$0.30 announced

First quarter 2024 earnings released: EPS: US$0.70 (vs US$0.83 in 1Q 2023)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Dolby Laboratories, Inc. to Report Q1, 2024 Results on Feb 01, 2024

Dolby Laboratories, Inc., Annual General Meeting, Feb 06, 2024

Full year 2023 earnings released: EPS: US$2.10 (vs US$1.84 in FY 2022)

Dolby Laboratories, Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2024

Dolby Laboratories, Inc. to Report Fiscal Year 2023 Results on Nov 16, 2023

Dolby Laboratories, Inc. Unveils New Dolby Atmos Innovation Coming to TCL TVS Ahead of IFA 2023

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2023

Third quarter 2023 earnings released: EPS: US$0.17 (vs US$0.40 in 3Q 2022)

Dolby Laboratories, Inc. to Report Q3, 2023 Results on Aug 03, 2023

Second quarter 2023 earnings released: EPS: US$1.00 (vs US$0.36 in 2Q 2022)

Dolby Laboratories, Inc. Announces Cash Dividend, Payable on May 23, 2023

Now 21% undervalued

Senior VP & Chief Marketing Officer recently sold €799k worth of stock

Independent Director recently sold €198k worth of stock

Independent Chairman recently sold €497k worth of stock

First quarter 2023 earnings released: EPS: US$0.83 (vs US$0.79 in 1Q 2022)

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on February 22, 2023

Dolby Laboratories, Inc. to Report Q1, 2023 Results on Feb 02, 2023

Dolby Laboratories, Inc., Annual General Meeting, Feb 07, 2023

Upcoming dividend of US$0.27 per share

Full year 2022 earnings released: EPS: US$1.84 (vs US$3.07 in FY 2021)

Dolby Laboratories, Inc. Provides Revenue Guidance for the Fiscal 2023

Dolby Laboratories, Inc. to Report Q4, 2022 Results on Nov 17, 2022

Upcoming dividend of US$0.25 per share

Third quarter 2022 earnings released: EPS: US$0.40 (vs US$0.54 in 3Q 2021)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2022

Dolby Laboratories, Inc. to Report Q3, 2022 Results on Aug 09, 2022

Insider recently sold €105k worth of stock

Second quarter 2022 earnings released: EPS: US$0.36 (vs US$0.75 in 2Q 2021)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2022 and Full Year Fiscal 2022

Dolby Laboratories, Inc. Announces Executive Changes

Dolby Laboratories, Inc. to Report Q2, 2022 Results on May 05, 2022

Dolby Laboratories, Inc. Announces General Availability of Dolby.io Transcode API

Upcoming dividend of US$0.25 per share

Dolby Laboratories, Inc. (NYSE:DLB) acquired Millicast, Inc. for $39 million.

Dolby Announces A Cash Dividend Payable on February 23, 2022

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: EPS US$3.07 (vs US$2.30 in FY 2020)

Insider recently sold €145k worth of stock

Senior VP & Chief Marketing Officer recently sold €232k worth of stock

Upcoming dividend of US$0.22 per share

Third quarter 2021 earnings released: EPS US$0.54 (vs US$0.67 in 3Q 2020)

Dolby Laboratories, Inc.(NYSE:DLB) dropped from Russell 3000 Growth Index

Dolby Laboratories Reaffirms Revenue Guidance for the Year 2021

Second quarter 2021 earnings released: EPS US$0.75 (vs US$0.88 in 2Q 2020)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Third Quarter and Second Half of 2021

New 90-day high: €81.50

Dolby Laboratories, Inc. Appoints Emily Rollins to the Board

Senior VP & Chief Marketing Officer recently sold €179k worth of stock

VP & Corporate Controller recently sold €169k worth of stock

Dolby Laboratories, Inc. Announces Retirement of Bill Jasper from Board

Revenue beats expectations

First quarter 2021 earnings released: EPS US$1.35 (vs US$0.49 in 1Q 2020)

Dolby Laboratories, Inc. to Report Q1, 2021 Results on Jan 28, 2021

New 90-day high: €78.50

Dolby Laboratories, Inc., Annual General Meeting, Feb 02, 2021

New 90-day high: €76.00

Independent Chairman recently sold €591k worth of stock